Expression of CD155 was associated with an M2-like phenotype and a higher expression of interleukin (IL)-10 and transforming growth factor (TGF)-β, as well as with colorectal tumor stages III/IV and with a shorter survival [67]. This evidence concerns the gene TGFB1 and colorectal neoplasm.